Anteris Technologies Global Corp. (AVR) 8-K Current Report: March 3, 2026
Filed: March 3, 2026
Health Care
Orthopedic, Prosthetic & Surgical Appliances & SuppliesAnteris Technologies Global Corp. (AVR) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
Anteris Technologies Global Corp. 8-K Mar 3, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • CFO Matthew McDonnell awarded supplemental RSU grant valued at $500,000, with share count set by March 4, 2026 closing price
- • Vesting schedule: equal one-third tranches on each of first three anniversaries of grant date, requiring continuous employment
- • Accelerated full vesting triggered by death, disability, or qualifying termination within 2 years post change-in-control
- • Framed as one-time recognition award — explicitly stated as not affecting McDonnell's regular 2026 annual equity target
- • RSUs settle in CHESS depositary interests, reflecting Company's dual-listed Australian structure
Other Anteris Technologies Global Corp. 8-K Filings
Get deeper insights on Anteris Technologies Global Corp.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.